Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim

Roberto Stasi, MD, PhD, Adrian Newland, Bertrand Godeau, Victor Priego, MD, Jean-Francois Viallard, Maria Fernanda Lopez Fernandez, Catherine Jia, Angela Lopez

Blood (2013) 122 (21): 1074.

https://doi.org/10.1182/blood.V122.21.1074.1074

Published: 2013

Journal Articles

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

Blood (2013) 121 (14): 2596–2606.

https://doi.org/10.1182/blood-2012-07-442392

Published: 2013

Includes: Supplemental data

Journal Articles

How I treat thrombocytopenia in pregnancy

Terry Gernsheimer, Andra H. James, Roberto Stasi

Blood (2013) 121 (1): 38–47.

https://doi.org/10.1182/blood-2012-08-448944

Published: 2013

Journal Articles

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Vivek L. Patel, Matthieu Mahévas, Soo Y. Lee, Roberto Stasi, Susanna Cunningham-Rundles, Bertrand Godeau, Julie Kanter, Ellis Neufeld, Tillmann Taube, Ugo Ramenghi, Shalini Shenoy, Mary J. Ward, Nino Mihatov, Vinay L. Patel, Philippe Bierling, Martin Lesser, Nichola Cooper, James B. Bussel

Blood (2012) 119 (25): 5989–5995.

https://doi.org/10.1182/blood-2011-11-393975

Published: 2012

Journal Articles

Sustained Hemostatic Platelet Counts in Adults with Immune Thrombocytopenia (ITP) Following Cessation of Treatment with the TPO Receptor Agonist Romiplostim: Report of 9 Cases,

James B Bussel, MD, Francesco Rodeghiero, MD, Roger M. Lyons, MD, Barry Firstenberg, Joanne Joseph, Craig M. Kessler, MD, Louis Terriou, Roberto Stasi, MD, PhD, Paul Chang, Susie Jun

Blood (2011) 118 (21): 3281.

https://doi.org/10.1182/blood.V118.21.3281.3281

Published: 2011

Journal Articles

ITP, interrupted

Roberto Stasi

Blood (2011) 118 (16): 4297–4298.

https://doi.org/10.1182/blood-2011-08-375097

Published: 2011

Journal Articles

The stingy bone marrow and the wasteful peripheral blood: a tale of two ITPs

Roberto Stasi

Blood (2011) 117 (21): 5553–5554.

https://doi.org/10.1182/blood-2011-03-342717

Published: 2011

Journal Articles

Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP).

Terry Gernsheimer, MD, David J. Kuter, MD, DPhil, Douglas B. Cines, MD, Roberto Stasi, Mathias J. Rummel, MD, PhD, Bertrand Godeau, MD, Matthew Guo, PhD, Janet Franklin, MD, MPH

Blood (2010) 116 (21): 3701.

https://doi.org/10.1182/blood.V116.21.3701.3701

Published: 2010

Journal Articles

Long-Term Outcome Following B-Cell Depletion Therapy with Rituximab In Children and Adults with Immune Thrombocytopenia (ITP)

Vivek L. Patel, MS, Matthieu Mahévas, MD, Roberto Stasi, MD, Susanna Cunningham-Rundles, PhD, Bertrand Godeau, MD, Soo Y. Lee, BS, Julie Kanter, MD, Ellis J. Neufeld, MD, PhD, Tillmann Taube, MD, Ugo Ramenghi, MD, Shalini Shenoy, MD, Mary J. Ward, PhD, Nino Mihatov, BS, Vinay L. Patel, BS, Philippe Bierling, MD, Nichola Cooper, MD, James B. Bussel, MD

Blood (2010) 116 (21): 72.

https://doi.org/10.1182/blood.V116.21.72.72

Published: 2010

Journal Articles

International consensus report on the investigation and management of primary immune thrombocytopenia

Blood (2010) 115 (2): 168–186.

https://doi.org/10.1182/blood-2009-06-225565

Published: 2010

Includes: Supplemental data

Journal Articles

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving Romiplostim or Medical Standard of Care.

Roberto Stasi, MD, Magaral Murali, Marc Michel, Jean-Francois Viallard, MD, PhD, Aristoteles Giagounidis, Ann Janssens, MD, Jason Legg, Mark Danese, Robert Deuson, PhD

Blood (2009) 114 (22): 1311.

https://doi.org/10.1182/blood.V114.22.1311.1311

Published: 2009

Journal Articles

Response: A case of rich fruit

Ameet Sarpatwari, Jodi B. Segal, James B. Bussel, Roberto Stasi, John Osborn

Blood (2009) 113 (24): 6260.

https://doi.org/10.1182/blood-2009-04-212506

Published: 2009

Journal Articles

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Blood (2009) 113 (11): 2386–2393.

https://doi.org/10.1182/blood-2008-07-162503

Published: 2009

Journal Articles

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

Roberto Stasi, Ameet Sarpatwari, Jodi B. Segal, John Osborn, Maria Laura Evangelista, Nichola Cooper, Drew Provan, Adrian Newland, Sergio Amadori, James B. Bussel

Blood (2009) 113 (6): 1231–1240.

https://doi.org/10.1182/blood-2008-07-167155

Published: 2009

Journal Articles

The Efficacy of H. pylori Eradication Therapy in H. pylori -Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.

Donald M. Arnold, MD, Ashley Bernotas, Ishac Nazi, PhD, Roberto Stasi, MD, Masataka Kuwana, MD, PhD, John G. Kelton, MD, FRCPC, Mark A. Crowther, MD

Blood (2008) 112 (11): 3413.

https://doi.org/10.1182/blood.V112.11.3413.3413

Published: 2008

Journal Articles

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab

Roberto Stasi, Nichola Cooper, Giovanni Del Poeta, Elisa Stipa, Maria Laura Evangelista, Elisabetta Abruzzese, Sergio Amadori

Blood (2008) 112 (4): 1147–1150.

https://doi.org/10.1182/blood-2007-12-129262

Published: 2008

Journal Articles

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

Carlo Visco, Marco Ruggeri, Maria Laura Evangelista, Roberto Stasi, Roberta Zanotti, Ilaria Giaretta, Achille Ambrosetti, Domenico Madeo, Giovanni Pizzolo, Francesco Rodeghiero

Blood (2008) 111 (3): 1110–1116.

https://doi.org/10.1182/blood-2007-09-111492

Published: 2008

Journal Articles

Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

Roberto Stasi, Giovanni Del Poeta, Elisa Stipa, Maria Laura Evangelista, Margherita M. Trawinska, Nichola Cooper, Sergio Amadori

Blood (2007) 110 (8): 2924–2930.

https://doi.org/10.1182/blood-2007-02-068999

Published: 2007

Journal Articles

Autoimmune Thrombocytopenic Purpura Complicating Chronic Lymphocytic Leukemia: Analysis of 60 Patients.

Carlo Visco, Roberto Stasi, Marco Ruggeri, Achille Ambrosetti, Stefania Fortuna, Francesco Frattini, Ilaria Giaretta, Roberta Zanotti, Domenico Madeo, Giovanni Pizzolo, Francesco Rodeghiero

Blood (2006) 108 (11): 4932.

https://doi.org/10.1182/blood.V108.11.4932.4932

Published: 2006

Journal Articles

Long Term Follow-Up of Patients with Immune Thrombocytopenic Purpura (ITP) Whose Initial Response to Rituximab Lasted a Minimum of 1 Year.

Vivek Patel, BS, Nino Mihatov, Nichola Cooper, MD, Roberto Stasi, MD, Susanna Cunningham-Rundles, PhD, James B. Bussel, MD

Blood (2006) 108 (11): 479.

https://doi.org/10.1182/blood.V108.11.479.479

Published: 2006

NARROW

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

How I treat thrombocytopenia in pregnancy

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Sustained Hemostatic Platelet Counts in Adults with Immune Thrombocytopenia (ITP) Following Cessation of Treatment with the TPO Receptor Agonist Romiplostim: Report of 9 Cases,

ITP, interrupted

The stingy bone marrow and the wasteful peripheral blood: a tale of two ITPs

Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP).

Long-Term Outcome Following B-Cell Depletion Therapy with Rituximab In Children and Adults with Immune Thrombocytopenia (ITP)

International consensus report on the investigation and management of primary immune thrombocytopenia

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving Romiplostim or Medical Standard of Care.

Response: A case of rich fruit

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

The Efficacy of H. pylori Eradication Therapy in H. pylori -Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

Autoimmune Thrombocytopenic Purpura Complicating Chronic Lymphocytic Leukemia: Analysis of 60 Patients.

Long Term Follow-Up of Patients with Immune Thrombocytopenic Purpura (ITP) Whose Initial Response to Rituximab Lasted a Minimum of 1 Year.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only